Posts by Lisa B. Nachtigall, MD
-
Biochemical Control Now Possible in Nearly All Patients with Acromegaly
In a study that spanned nearly 40 years of follow-up at Mass General, 93% of patients with acromegaly achieved normalization of normal insulin-like growth factor 1.
Biography
Dr. Lisa Nachtigall is the Clinical Director of the Neuroendocrine and Pituitary Tumor Clinical Center at Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School. Her primary clinical focus is pituitary disorders and the treatment of patients with acromegaly. She has extensive clinical experience in neuroendocrine disorders and has published clinical research papers in this area. She has received awards for teaching and clinical investigation.
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.